Competing to offer a comprehensive genomic profiling service for solid or hematology oncology tumor samples is challenging, especially as panels increase in size and complexity. QIAGEN Clinical Insight (QCI) Interpret One is clinical decision support software integrated with professional variant interpretation services that enables rapid, evidence-based reporting of oncology NGS tests at scale.

Connected to the world’s most comprehensive, manually curated knowledge base that is updated weekly, QCI Interpret One dynamically computes variant classifications according to AMP/ASCO/CAP and ACMG/AMP guidelines with full transparency. Users get access to over 200,000 pre-formulated, oncologist-reviewed variant interpretation summaries and can build customizable, oncologist-ready reports with the latest diagnostic and prognostic information, as well as biomarker-directed therapies and clinical trials.

In this webinar, attendees will learn:

How QCI Interpret One computes variant classifications
How simple it is to submit variants for professional interpretation via the software
How QCI Interpret One eliminates the need for variant curation
How users can generate customizable, oncologist-ready reports according to AMP/ASCO/CAP guidelines for therapeutic, prognostic, and diagnostic actionability

Speakers:
Beate Litzenburger, PhD
Global Product Director of Oncology
QIAGEN Digital Insights


Sheryl Elkin, PhD
Chief Scientific Officer
N-of-One, a QIAGEN company